Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 10/20 | 0.69 |
| ▸ | MAPT | P10636 | 10/20 | 0.69 |
| ▸ | MEN1 | O00255 | 10/20 | 0.69 |
| ▸ | KMT2A | Q03164 | 10/20 | 0.69 |
| ▸ | SMN1; SMN2 | Q16637 | 9/20 | 0.69 |
| ▸ | NPC1 | O15118 | 9/20 | 0.69 |
| ▸ | KDM4E | B2RXH2 | 8/20 | 0.69 |
| ▸ | HPGD | P15428 | 8/20 | 0.69 |
| ▸ | RAB9A | P51151 | 8/20 | 0.69 |
| ▸ | POLB | P06746 | 7/20 | 0.69 |
| ▸ | GAA | P10253 | 7/20 | 0.69 |
| ▸ | HSD17B10 | Q99714 | 6/20 | 0.69 |
| ▸ | GFER | P55789 | 5/20 | 0.69 |
| ▸ | GLA | P06280 | 5/20 | 0.69 |
| ▸ | TP53 | P04637 | 4/20 | 0.69 |
| ▸ | RXFP1 | Q9HBX9 | 3/20 | 0.69 |
| ▸ | RECQL | P46063 | 2/20 | 0.69 |
| ▸ | CACNA1B | Q00975 | 2/20 | 0.66 |
| ▸ | APBA1 | Q02410 | 2/20 | 0.66 |
| ▸ | NFKB1 | P19838 | 3/20 | 0.65 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL417825 | 0.93 | ALDH1A1 (0.71) | ALDH1A1MAPTMEN1KMT2ASMN1; SMN2 | |
| SCHEMBL419961 | 0.93 | MEN1 (0.77) | ALDH1A1MAPTMEN1KMT2ASMN1; SMN2 | |
| SCHEMBL10002475 | 0.93 | ALDH1A1 (0.71) | ALDH1A1MAPTMEN1KMT2ASMN1; SMN2 | |
| SCHEMBL30307784 | 0.93 | ALDH1A1 (0.74) | ALDH1A1MAPTMEN1KMT2ASMN1; SMN2 | |
| SCHEMBL28312335 | 0.93 | ALDH1A1 (0.74) | ALDH1A1MAPTMEN1KMT2ASMN1; SMN2 | |
| SCHEMBL159873 | 0.93 | ALDH1A1 (0.74) | ALDH1A1MAPTMEN1KMT2ASMN1; SMN2 | |
| SCHEMBL30533210 | 0.91 | MEN1 (0.73) | ALDH1A1MAPTMEN1KMT2ASMN1; SMN2 | |
| SCHEMBL1655753 | 0.91 | MEN1 (0.73) | ALDH1A1MAPTMEN1KMT2ASMN1; SMN2 | |
| SCHEMBL22906080 | 0.91 | ALDH1A1 (0.58) | ALDH1A1MAPTMEN1KMT2ASMN1; SMN2 | |
| SCHEMBL6263502 | 0.91 | ALDH1A1 (0.58) | ALDH1A1MAPTMEN1KMT2ASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10961202-B2 | Bis-benzimidazole compounds and methods of using the same | THE SCRIPPS RESEARCH INSTITUTE (US) | 2021-03-30 | — | — | US | disclosed |
| US-10961202-B2 | Bis-benzimidazole compounds and methods of using the same | THE SCRIPPS RESEARCH INSTITUTE (US) | 2021-03-30 | — | — | US | disclosed |
| US-20190152924-A1 | BIS-BENZIMIDAZOLE COMPOUNDS AND METHODS OF USING THE SAME | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED | 2019-05-23 | — | — | US | disclosed |
| US-20190152924-A1 | BIS-BENZIMIDAZOLE COMPOUNDS AND METHODS OF USING THE SAME | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED | 2019-05-23 | — | — | US | disclosed |
| EP-0410929-A2 | Linear polymers | CIBA-GEIGY AG (CH) | 1991-01-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10961202-B2 | Bis-benzimidazole compounds and methods of using the same | HNRNPH1, HNRNPH3, HNRNPUL2 | ALDH1A1 3412/4885MAPT 60/4885MEN1 1360/4885 |
| US-20190152924-A1 | BIS-BENZIMIDAZOLE COMPOUNDS AND METHODS OF USING THE SAME | HNRNPH1, HNRNPH3, HNRNPUL2 | ALDH1A1 3412/4885MAPT 60/4885MEN1 1360/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.